Clinical trial · Observational
Incidental Cancer in Familial Adenomatous Polyposis
Incidental Cancer in Colectomy Specimens From Patients With Familial Adenomatous Polyposis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- incidental cancer
- description
- familial adenomatous polyposis with incidental cancer
Primary outcomes (1)
- measure
- incidental cancer
- timeFrame
- 2 or 3 week
- description
- Familial Adenomatous Polyposis with cancer
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * diagnosed with Familial Adenomatous Polyposis Exclusion Criteria: * did not receive surgical treatment * data deficiencies
References
Publications (0)
Data not yet available